Sector: Consumer Non-Cyclicals | Industry: Food Processing |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 2503 S Hanley Rd ST. LOUIS MO 63144 |
Tel: | N/A |
Website: | https://www.postholdings.com |
IR: | See website |
Key People | ||
Robert V. Vitale President, Chief Executive Officer, Director | Matthew J. Mainer Senior Vice President, Chief Financial Officer, Treasurer | Nicolas Catoggio President, Chief Executive Officer of Post Consumer Brands |
Mark W. Westphal President of Foodservice | Jeff A. Zadoks Chief Operating Officer, Executive Vice President | Diedre Johnston Gray Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary |
Business Overview |
Post Holdings, Inc. is a consumer-packaged goods holding company. The Company operates through four segments: Post Consumer Brands, Weetabix, Foodservice and Refrigerated Retail. Post Consumer Brands segment includes North American ready-to-eat (RTE) cereal and Peter Pan nut butter. Weetabix segment includes primarily the United Kingdom (the U.K.) RTE cereal, muesli and protein-based ready-to-drink shakes. The Foodservice segment sells primarily egg and potato products. The Refrigerated Retail segment primarily sells side dishes, egg, cheese and sausage products. The Company also operates a pet food business, which includes the brands, such as Rachael Ray, Nutrish, Nature's Recipe, 9Lives, Kibbles 'n Bits and Gravy Train. This business also includes private-label pet food assets and manufacturing and distribution facilities. The Company also includes two manufacturing and warehousing facilities in Visalia, California. |
Financial Overview |
For the three months ended 31 December 2023, Post Holdings Inc revenues increased 26% to $1.97B. Net income decreased 4% to $88.1M. Revenues reflect Post Consumer brand segment increase of 78% to $988.6M, Weetabix segment increase of 9% to $129.1M, Eliminations segment increase from $0K to $200K. Net income was offset by Foodservice segment income decrease of 4% to $75.7M, Weetabix segment income decrease of 2% to $21M. |
Employees: | 11,430 as of Nov 1, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $12,317M as of Dec 31, 2023 |
Annual revenue (TTM): | $7,391M as of Dec 31, 2023 |
EBITDA (TTM): | $1,137M as of Dec 31, 2023 |
Net annual income (TTM): | $297.50M as of Dec 31, 2023 |
Free cash flow (TTM): | $494.90M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $6,165M as of Dec 31, 2023 |
Shares outstanding: | 60,681,218 as of Jan 29, 2024 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |